Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E, memory and Alzheimer's disease

H S Soininen1, P J Riekkinen

  • 1Dept of Neurology, Kuopio University, Finland.

Trends in Neurosciences
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic Implications.

CNS drugs·2015
Same author

Persisting axonal degeneration in the hippocampus after transection of the fimbria-fornix.

Restorative neurology and neuroscience·2011
Same author

Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland.

European journal of neurology·2002
Same author

Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.

Biological psychiatry·2000
Same author

Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor.

Epilepsy research·1999
Same author

Long-term treatment with vigabatrin - 10 years of clinical experience.

Seizure·1999

The Apolipoprotein E (ApoE) epsilon 4 allele is linked to increased Alzheimer's disease (AD) risk and memory decline. This genetic factor may worsen brain changes and cognitive deficits in both AD patients and the elderly.

Area of Science:

  • Neuroscience
  • Genetics
  • Alzheimer's Disease Research

Background:

  • Apolipoprotein E (ApoE) epsilon 4 is a known risk factor for Alzheimer's disease (AD).
  • AD is characterized by neuronal damage, particularly in memory-related medial temporal lobe structures.
  • ApoE influences nerve regeneration and synaptogenesis.

Purpose of the Study:

  • To investigate the impact of the ApoE epsilon 4 allele on brain structure and cognitive function in Alzheimer's disease and non-demented elderly individuals.
  • To explore the association between ApoE genotype and medial temporal lobe atrophy and memory impairment.

Main Methods:

  • Analysis of brain imaging (MRI) for hippocampal volume.
  • Assessment of cognitive function, including delayed memory and learning ability.

Related Experiment Videos

  • Comparison of individuals with different ApoE genotypes (e.g., epsilon 4/4 vs. others).

    • Main Results:

    • Individuals homozygous for ApoE epsilon 4 show increased beta A4 amyloid accumulation and cholinergic neuron deficits.
    • AD patients with two ApoE epsilon 4 alleles exhibit greater hippocampal volume loss and memory impairment.
    • Even in non-demented elderly, the epsilon 4 allele is associated with hippocampal volume changes and reduced learning ability.

    Conclusions:

    • The ApoE epsilon 4 allele may exacerbate medial temporal lobe atrophy and memory deficits in Alzheimer's disease.
    • ApoE epsilon 4's influence on cognitive function extends to non-demented elderly individuals, affecting learning.
    • This genetic factor plays a significant role in age-related cognitive decline and AD pathogenesis.